Overview

Laparoscopic Surgery and Abdominal Compliance

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The objective of the study is to describe factors influencing abdominal compliance during laparoscopic surgery, including neuromuscular blocking agents (NMBA). The use of NMBA is randomized and blinded from the surgeons and the anesthesiologist. The abdominal compliance is measured by pressure/volume relationship.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
CHU de Reims
Treatments:
Cisatracurium
Neuromuscular Blocking Agents
Propofol
Sufentanil
Criteria
Inclusion Criteria:

- elective abdominal laparoscopy (cholecystectomy, colectomy, gastric bypass, sleeve
gastrectomy, hepatic resection, splenectomy, hernial surgery, explorative laparoscopy)

- >18 yo

- patients who accept the protocol and sign it

- patients affiliated at the social security

Exclusion Criteria:

- formal indication of NMBA use (predictive difficult tracheal intubation, predictive
difficult facial ventilation)

- patients who needs a crush induction

- NMBA allergia

- patients who present a contraindication to the propofol or sufentanil

- pregnancy

- breastfeeding womens

- patients protected by the law